-
1
-
-
33846466508
-
Epidemiology of invasive candidiasis: A persistent public health problem
-
DOI 10.1128/CMR.00029-06
-
Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev. 2007;20:133-63. (Pubitemid 46167771)
-
(2007)
Clinical Microbiology Reviews
, vol.20
, Issue.1
, pp. 133-163
-
-
Pfaller, M.A.1
Diekema, D.J.2
-
2
-
-
20144388435
-
Epidemiology and predictors of mortality in cases of Candida bloodstream infection: Results from population-based surveillance, Barcelona, Spain, from 2002 to 2003
-
Barcelona Candidemia Project Study Group
-
Almirante B, Rodríguez D, Park BJ, Cuenca-Estrella M, Planes AM, Almela M, et al., Barcelona Candidemia Project Study Group. Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, Barcelona, Spain, from 2002 to 2003. J Clin Microbiol. 2005;43:1829-35.
-
(2005)
J Clin Microbiol
, vol.43
, pp. 1829-1835
-
-
Almirante, B.1
Rodríguez, D.2
Park, B.J.3
Cuenca-Estrella, M.4
Planes, A.M.5
Almela, M.6
-
3
-
-
55649087988
-
Epidemiology of candidemia in intensive care units
-
Bouza E, Muñoz P. Epidemiology of candidemia in intensive care units. Int J Antimicrob Agents. 2008;32 Suppl 2:S87-91.
-
(2008)
Int J Antimicrob Agents
, vol.32
, Issue.SUPPL. 2
-
-
Bouza, E.1
Muñoz, P.2
-
4
-
-
0033955216
-
Candidemia in allogeneic blood and marrow transplant recipients: Evolution of risk factors after the adoption of prophylactic fluconazole
-
DOI 10.1086/315193
-
Marr KA, Seidel K, White TC, Bowden RA. Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption ofprophylactic fluconazole. J Infect Dis. 2000;181:309-16. (Pubitemid 30049062)
-
(2000)
Journal of Infectious Diseases
, vol.181
, Issue.1
, pp. 309-316
-
-
Marr, K.A.1
Seidel, K.2
White, T.C.3
Bowden, R.A.4
-
5
-
-
70350107583
-
Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): Stable incidence but changing epidemiology of a still frequently lethal infection
-
Sipsas NV, Lewis RE, Tarrand J, Hachem R, Rolston KV, Raad II, et al. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer. 2009;115:4745-52.
-
(2009)
Cancer
, vol.115
, pp. 4745-4752
-
-
Sipsas, N.V.1
Lewis, R.E.2
Tarrand, J.3
Hachem, R.4
Rolston, K.V.5
Raad, I.I.6
-
6
-
-
35748957767
-
Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients
-
DOI 10.1111/j.1365-2141.2007.06812.x
-
Barnes PD, Marr KA. Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients. Br J Haematol. 2007;139:519-31. (Pubitemid 350043811)
-
(2007)
British Journal of Haematology
, vol.139
, Issue.4
, pp. 519-531
-
-
Barnes, P.D.1
Marr, K.A.2
-
7
-
-
54849130900
-
The First European Conference on Infections in Leukaemia -ECIL1: A current perspective
-
Meunier F, Lukan C. The First European Conference on Infections in Leukaemia -ECIL1: a current perspective. Eur J Cancer. 2008;44:2112-7.
-
(2008)
Eur J Cancer
, vol.44
, pp. 2112-2117
-
-
Meunier, F.1
Lukan, C.2
-
8
-
-
58149088852
-
Treatment of invasive fungal infections in cancer patients- recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)
-
Böhme A, Ruhnke M, Buchheidt D, Cornely OA, Einsele H, Enzensberger R, et al. Treatment of invasive fungal infections in cancer patients- recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol. 2009;88:97-110.
-
(2009)
Ann Hematol
, vol.88
, pp. 97-110
-
-
Böhme, A.1
Ruhnke, M.2
Buchheidt, D.3
Cornely, O.A.4
Einsele, H.5
Enzensberger, R.6
-
9
-
-
60549098868
-
Clinical practice guidelines for the management of candidiasis: 2009 Update by the Infectious Diseases Society of America
-
Infectious Diseases Society of America
-
Pappas PG, Kauffman CA, Andes D, Benjamin Jr DK, Calandra TF, Edwards Jr JE, et al., Infectious Diseases Society of America. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503-35.
-
(2009)
Clin Infect Dis
, vol.48
, pp. 503-535
-
-
Pappas, P.G.1
Kauffman, C.A.2
Andes, D.3
Benjamin Jr., D.K.4
Calandra, T.F.5
Edwards Jr., J.E.6
-
10
-
-
10344251462
-
Management of invasive candidal infections: Results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature
-
Anaissie EJ, Darouiche RO, Abi-Said D, Uzun O, Mera J, Gentry LO, et al. Management of invasive candidal infections: results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature. Clin Infect Dis. 1996;23:964-72. (Pubitemid 26367478)
-
(1996)
Clinical Infectious Diseases
, vol.23
, Issue.5
, pp. 964-972
-
-
Anaissie, E.J.1
Darouiche, R.O.2
Abi-Said, D.3
Uzun, O.4
Mera, J.5
Gentry, L.O.6
Williams, T.7
Kontoyiannis, D.P.8
Karl, C.L.9
Bodey, G.P.10
-
11
-
-
8544284077
-
Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients
-
DOI 10.1007/BF01726360
-
Phillips P, Shafran S, Garber G, Rotstein C, Smaill F, Fong I, et al. Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group. Eur J Clin Microbiol Infect Dis. 1997;16:337-45. (Pubitemid 27271820)
-
(1997)
European Journal of Clinical Microbiology and Infectious Diseases
, vol.16
, Issue.5
, pp. 337-345
-
-
Phillips, P.1
Shafran, S.2
Garber, G.3
Rotstein, C.4
Smaill, F.5
Fong, I.6
Salit, I.7
Miller, M.8
Williams, K.9
Conly, J.M.10
Singer, J.11
Ioannou, S.12
-
12
-
-
0028046352
-
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia
-
DOI 10.1056/NEJM199411173312001
-
Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med. 1994;331:1325-30. (Pubitemid 24347001)
-
(1994)
New England Journal of Medicine
, vol.331
, Issue.20
, pp. 1325-1330
-
-
Rex, J.H.1
Bennett, J.E.2
Sugar, A.M.3
Pappas, P.G.4
Van Der, H.C.M.5
Edwards, J.E.6
Washburn, R.G.7
Scheld, W.M.8
Karchmer, A.W.9
Dine, A.P.10
Levenstein, M.J.11
Douglas, W.C.12
-
13
-
-
26944446579
-
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: A randomised non-inferiority trial
-
DOI 10.1016/S0140-6736(05)67490-9, PII S0140673605674909
-
Kullberg BJ, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, Rex JH, et al. Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial. Lancet. 2005;366:1435-42. (Pubitemid 41483809)
-
(2005)
Lancet
, vol.366
, Issue.9495
, pp. 1435-1442
-
-
Kullberg, B.J.1
Sobel, J.D.2
Ruhnke, M.3
Pappas, P.G.4
Viscoli, C.5
Rex, J.H.6
Cleary, J.D.7
Rubinstein, E.8
Church, L.W.P.9
Brown, J.M.10
Schlamm, H.T.11
Oborska, I.T.12
Hilton, F.13
Hodges, M.R.14
-
14
-
-
0037137576
-
Comparison of caspofungin and amphotericin B for invasive candidiasis
-
DOI 10.1056/NEJMoa021585
-
Mora-Duarte J, Betts R, Rotstein C, Colombo AL, Thompson-Moya L, Smietana J, et al. Comparison of caspofungin and amphotericin B for invasive candidiasis. Caspofungin Invasive Candidiasis Study Group. N Engl J Med. 2002;347:2020-9. (Pubitemid 35461658)
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.25
, pp. 2020-2029
-
-
Mora-Duarte, J.1
Betts, R.2
Rotstein, C.3
Lopes, C.A.4
Thompson-Moya, L.5
Smietana, J.6
Lupinacci, R.7
Sable, C.8
Kartsonis, N.9
Perfect, J.10
-
15
-
-
4644346490
-
Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia
-
Walsh TJ, Teppler H, Donowitz GR, Maertens JA, Baden LR, Dmoszynska A, et al. Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia. N Engl J Med. 2004;351:1391-402.
-
(2004)
N Engl J Med
, vol.351
, pp. 1391-1402
-
-
Walsh, T.J.1
Teppler, H.2
Donowitz, G.R.3
Maertens, J.A.4
Baden, L.R.5
Dmoszynska, A.6
-
16
-
-
34247564562
-
Micafungin versus liposomal amphotericin B for candidaemia andinvasive candidosis: A phase III randomised double-blind trial
-
Micafungin Invasive Candidiasis Working Group
-
Kuse ER, Chetchotisakd P, Da Cunha CA, Ruhnke M, Barrios C, Raghunadharao D, et al., Micafungin Invasive Candidiasis Working Group. Micafungin versus liposomal amphotericin B for candidaemia andinvasive candidosis: a phase III randomised double-blind trial. Lancet. 2007;369:1519-27.
-
(2007)
Lancet
, vol.369
, pp. 1519-1527
-
-
Kuse, E.R.1
Chetchotisakd, P.2
Da Cunha, C.A.3
Ruhnke, M.4
Barrios, C.5
Raghunadharao, D.6
-
17
-
-
53049099239
-
Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: Substudy of a randomized double-blind trial
-
Micafungin Invasive Candidiasis Study Group
-
Queiroz-Telles F, Berezin E, Leverger G, Freire A, Van der Vyver A, Chotpitayasunondh T, et al., Micafungin Invasive Candidiasis Study Group. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Pediatr Infect Dis J. 2008;27:820-6.
-
(2008)
Pediatr Infect Dis J
, vol.27
, pp. 820-826
-
-
Queiroz-Telles, F.1
Berezin, E.2
Leverger, G.3
Freire, A.4
Van Der Vyver, A.5
Chotpitayasunondh, T.6
-
18
-
-
34848928703
-
Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis
-
DOI 10.1086/520980
-
Pappas PG, Rotstein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, et al. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis. 2007;45:883-93. (Pubitemid 47580382)
-
(2007)
Clinical Infectious Diseases
, vol.45
, Issue.7
, pp. 883-893
-
-
Pappas, P.G.1
Rotstein, C.M.F.2
Betts, R.F.3
Nucci, M.4
Talwar, D.5
De Waele, J.J.6
Vazquez, J.A.7
Dupont, B.F.8
Horn, D.L.9
Ostrosky-Zeichner, L.10
Reboli, A.C.11
Suh, B.12
Digumarti, R.13
Wu, C.14
Kovanda, L.L.15
Arnold, L.J.16
Buell, D.N.17
-
19
-
-
34250341787
-
Anidulafungin versus fluconazole for invasive candidiasis
-
Reboli AC, Rotstein C, Pappas PG, Chapman SW, Kett DH, Kumar D, et al., Anidulafungin Study Group. Anidulafungin versus fluconazole for invasive candidiasis. N Engl J Med. 2007;356:2472-82. (Pubitemid 46919773)
-
(2007)
New England Journal of Medicine
, vol.356
, Issue.24
, pp. 2472-2482
-
-
Reboli, A.C.1
Rotstein, C.2
Pappas, P.G.3
Chapman, S.W.4
Kett, D.H.5
Kumar, D.6
Betts, R.7
Wible, M.8
Goldstein, B.P.9
Schranz, J.10
Krause, D.S.11
Walsh, T.J.12
-
21
-
-
0033545538
-
Liposomal amphotericin b for empirical therapy in patients with persistent fever and neutropenia
-
DOI 10.1056/NEJM199903113401004
-
Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, et al. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group. N Engl J Med. 1999;340:764-71. (Pubitemid 29114295)
-
(1999)
New England Journal of Medicine
, vol.340
, Issue.10
, pp. 764-771
-
-
Walsh, T.J.1
Finberg, R.W.2
Arndt, C.3
Hiemenz, J.4
Schwartz, C.5
Bodensteiner, D.6
Pappas, P.7
Seibel, N.8
Greenberg, R.N.9
Dummer, S.10
Schuster, M.11
Holcenberg, J.S.12
Dismukes, W.E.13
-
22
-
-
34447281527
-
Impact of early central venous catheter removal on outcome in patients with candidaemia
-
Barcelona Candidemia Project Study Group
-
Rodríguez D, Park BJ, Almirante B, Cuenca-Estrella M, Planes AM, Mensa J, et al., Barcelona Candidemia Project Study Group. Impact of early central venous catheter removal on outcome in patients with candidaemia. Clin Microbiol Infect. 2007;13:788-93.
-
(2007)
Clin Microbiol Infect
, vol.13
, pp. 788-793
-
-
Rodríguez, D.1
Park, B.J.2
Almirante, B.3
Cuenca-Estrella, M.4
Planes, A.M.5
Mensa, J.6
-
23
-
-
2342481897
-
Management of central venous catheters in patients with cancer and candidemia
-
DOI 10.1086/382874
-
Raad I, Hanna H, Boktour M, Girgawy E, Danawi H, Mardani M, et al. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis. 2004;38:1119-27. (Pubitemid 38951258)
-
(2004)
Clinical Infectious Diseases
, vol.38
, Issue.8
, pp. 1119-1127
-
-
Raad, I.1
Hanna, H.2
Boktour, M.3
Girgawy, E.4
Danawi, H.5
Mardani, M.6
Kontoyiannis, D.7
Darouiche, R.8
Hachem, R.9
Bodey, G.P.10
-
24
-
-
0026008790
-
Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy
-
Anaissie E, Bodey GP, Kantarjian H, David C, Barnett K, Bow E, et al. Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. Am J Med. 1991;91:142-50.
-
(1991)
Am J Med
, vol.91
, pp. 142-150
-
-
Anaissie, E.1
Bodey, G.P.2
Kantarjian, H.3
David, C.4
Barnett, K.5
Bow, E.6
-
25
-
-
0025942177
-
Hepatosplenic candidiasis: Successful treatment with fluconazole
-
Kauffman CA, Bradley SF, Ross SC, Weber DR. Hepatosplenic candidiasis: successful treatment with fluconazole. Am J Med 1. 1991;91:137-41.
-
(1991)
Am J Med 1
, vol.91
, pp. 137-141
-
-
Kauffman, C.A.1
Bradley, S.F.2
Ross, S.C.3
Weber, D.R.4
-
26
-
-
0027324048
-
Successful treatment of disseminated candidiasis reistant to amphotericin B by liposomal amphotericin B: A case report
-
Gokhale PC, Barapatre RJ, Advani SH, Kshirsagar NA, Pandya SK. Successful treatment of disseminated candidiasis resistant to amphotericin B by liposomal amphotericin B: a case report. J Cancer Res Clin Oncol. 1993;119:569-71. (Pubitemid 23221031)
-
(1993)
Journal of Cancer Research and Clinical Oncology
, vol.119
, Issue.10
, pp. 569-571
-
-
Gokhale, P.C.1
Barapatre, R.J.2
Advani, S.H.3
Kshirsagar, N.A.4
Pandya, S.K.5
-
27
-
-
0036828001
-
Successful treatment with caspofungin of hepatosplenic candidiasis resistant to liposomal amphotericin B [2]
-
Sorà F, Chiusolo P, Piccirillo N, Pagano L, Laurenti L, Farina G, et al. Successful treatment with caspofungin of hepatosplenic candidiasis resistant to liposomal amphotericin B. Clin Infect Dis. 2002;35:1135-6. (Pubitemid 35239476)
-
(2002)
Clinical Infectious Diseases
, vol.35
, Issue.9
, pp. 1135-1136
-
-
Sora, F.1
Chiusolo, P.2
Piccirillo, N.3
Pagano, L.4
Laurenti, L.5
Farina, G.6
Sica, S.7
Leone, G.8
-
28
-
-
39749091121
-
Adjuvant corticosteroid therapy for chronic disseminated candidiasis
-
DOI 10.1086/527390
-
Legrand F, Lecuit M, Dupont B, Bellaton E, Huerre M, Rohrlich PS, et al. Adjuvant corticosteroid therapy for chronic disseminated candidiasis. Clin Infect Dis. 2008;46:696-702. (Pubitemid 351321553)
-
(2008)
Clinical Infectious Diseases
, vol.46
, Issue.5
, pp. 696-702
-
-
Legrand, F.1
Lecuit, M.2
Dupont, B.3
Bellaton, E.4
Huerre, M.5
Rohrlich, P.-S.6
Lortholary, O.7
-
29
-
-
33144468942
-
Fungal infections in solid organ transplantation
-
DOI 10.1517/14656566.7.3.297
-
Marik PE. Fungal infections in solid organ transplantation. Expert Opin Pharmacother. 2006;7:297-305. (Pubitemid 43263247)
-
(2006)
Expert Opinion on Pharmacotherapy
, vol.7
, Issue.3
, pp. 297-305
-
-
Marik, P.E.1
-
30
-
-
77950278696
-
Invasive fungal infections among organ transplant recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET)
-
Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis. 2010;50:1101-11.
-
(2010)
Clin Infect Dis
, vol.50
, pp. 1101-1111
-
-
Pappas, P.G.1
Alexander, B.D.2
Andes, D.R.3
Hadley, S.4
Kauffman, C.A.5
Freifeld, A.6
-
31
-
-
38649141183
-
Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: Correlation with outcome in solid organ transplant recipients with cryptococcosis
-
DOI 10.1128/AAC.00990-07
-
Kontoyiannis DP, Lewis RE, Alexander BD, Lortholary O, Dromer F, Gupta KL, et al. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother. 2008;52:735-8. (Pubitemid 351170854)
-
(2008)
Antimicrobial Agents and Chemotherapy
, vol.52
, Issue.2
, pp. 735-738
-
-
Kontoyiannis, D.P.1
Lewis, R.E.2
Alexander, B.D.3
Lortholary, O.4
Dromer, F.5
Gupta, K.L.6
John, G.T.7
Del, B.R.8
Klintmalm, G.B.9
Somani, J.10
Lyon, G.M.11
Pursell, K.12
Stosor, V.13
Munoz, P.14
Limaye, A.P.15
Kalil, A.C.16
Pruett, T.L.17
Garcia-Diaz, J.18
Humar, A.19
Houston, S.20
House, A.A.21
Wray, D.22
Orloff, S.23
Dowdy, L.A.24
Fisher, R.A.25
Heitman, J.26
Albert, N.D.27
Wagener, M.M.28
Singh, N.29
more..
-
32
-
-
33847064677
-
Cryptococcus neoformans in organ transplant recipients: Impact of calcineurin-inhibitor agents on mortality
-
Singh N, Alexander BD, Lortholary O, Dromer F, Gupta KL, John GT, et al. Cryptococcus neoformans in organ transplant recipients: impact of calcineurin-inhibitor agents on mortality. J Infect Dis. 2007;195:756-64.
-
(2007)
J Infect Dis
, vol.195
, pp. 756-764
-
-
Singh, N.1
Alexander, B.D.2
Lortholary, O.3
Dromer, F.4
Gupta, K.L.5
John, G.T.6
-
33
-
-
75749092958
-
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america
-
Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 2010;50:291-322.
-
(2010)
Clin Infect Dis
, vol.50
, pp. 291-322
-
-
Perfect, J.R.1
Dismukes, W.E.2
Dromer, F.3
Goldman, D.L.4
Graybill, J.R.5
Hamill, R.J.6
-
34
-
-
0033998663
-
Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans
-
Del Poeta M, Cruz MC, Cardenas ME, Perfect JR, Heitman J. Synergistic antifungal activities of bafilomycin A(1), fluconazole, and the pneumocandin MK-0991/caspofungin acetate (L-743,873) with calcineurin inhibitors FK506 and L-685,818 against Cryptococcus neoformans. Antimicrob Agents Chemother. 2000;44:739-46.
-
(2000)
Antimicrob Agents Chemother
, vol.44
, pp. 739-746
-
-
Del Poeta, M.1
Cruz, M.C.2
Cardenas, M.E.3
Perfect, J.R.4
Heitman, J.5
-
35
-
-
71249106155
-
Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species
-
Mann PA, McNicholas PM, Chau AS, Patel R, Mendrick C, Ullmann AJ, et al. Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species. Antimicrob Agents Chemother. 2009;53:5026-34.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 5026-5034
-
-
Mann, P.A.1
McNicholas, P.M.2
Chau, A.S.3
Patel, R.4
Mendrick, C.5
Ullmann, A.J.6
-
37
-
-
33644893928
-
Invasive fungal infections in low-risk liver transplant recipients: A multi-center prospective observational study
-
DOI 10.1111/j.1600-6143.2005.01176.x
-
Pappas PG, Andes D, Schuster M, Hadley S, Rabkin J, Merion RM, et al. Invasive fungal infections in low-risk liver transplant recipients: a multi-center prospective observational study. Am J Transplant. 2006;6:386-91. (Pubitemid 43382176)
-
(2006)
American Journal of Transplantation
, vol.6
, Issue.2
, pp. 386-391
-
-
Pappas, P.G.1
Andes, D.2
Schuster, M.3
Hadley, S.4
Rabkin, J.5
Merion, R.M.6
Kauffman, C.A.7
Huckabee, C.8
Cloud, G.A.9
Dismukes, W.E.10
Karchmer, A.W.11
-
38
-
-
61849170634
-
Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients
-
Fortun J, Martín-Davila P, Montejo M, Muñoz P, Cisneros JM, Ramos A, et al. Prophylaxis with caspofungin for invasive fungal infections in high-risk liver transplant recipients. Transplantation. 2009;87:424-35.
-
(2009)
Transplantation
, vol.87
, pp. 424-435
-
-
Fortun, J.1
Martín-Davila, P.2
Montejo, M.3
Muñoz, P.4
Cisneros, J.M.5
Ramos, A.6
-
39
-
-
27744601940
-
Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection
-
DOI 10.1097/01.tp.0000173774.74388.49
-
Singh N, Lortholary O, Alexander BD, Gupta KL, John GT, Pursell KJ, et al. Antifungal management practices and evolution of infection in organ transplant recipients with Cryptococcus neoformans infection. Transplantation. 2005;80:1033-9. (Pubitemid 41611924)
-
(2005)
Transplantation
, vol.80
, Issue.8
, pp. 1033-1039
-
-
Singh, N.1
Lortholary, O.2
Alexander, B.D.3
Gupta, K.L.4
John, G.T.5
Pursell, K.J.6
Munoz, P.7
Klintmalm, G.B.8
Stosor, V.9
Busto, R.D.10
Limaye, A.P.11
Somani, J.12
Lyon, M.13
Houston, S.14
House, A.A.15
Pruett, T.L.16
Orloff, S.17
Humar, A.18
Dowdy, L.A.19
Garcia-Diaz, J.20
Kalil, A.C.21
Fisher, R.A.22
Heitman, J.23
Husain, S.24
more..
-
40
-
-
17644405088
-
Successful use of amphotericin B lipid complex in the treatment of cryptococcosis
-
Baddour LM, Perfect JR, Ostrosky-Zeichner L. Successful use of amphotericin B lipid complex in the treatment of cryptococcosis. Clin Infect Dis. 2005;40 Suppl 6:S409-13.
-
(2005)
Clin Infect Dis
, vol.40
, Issue.SUPPL. 6
-
-
Baddour, L.M.1
Perfect, J.R.2
Ostrosky-Zeichner, L.3
-
41
-
-
0038282815
-
A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations
-
DOI 10.1016/S0149-2918(03)80125-X
-
Barrett JP, Vardulaki KA, Conlon C, Cooke J, Daza-Ramírez P, Evans EG, et al. A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations. Clin Ther. 2003;25:1295-320. (Pubitemid 36677281)
-
(2003)
Clinical Therapeutics
, vol.25
, Issue.5
, pp. 1295-1320
-
-
Barrett, J.P.1
Vardulaki, K.A.2
Conlon, C.3
Cooke, J.4
Daza-Ramirez, P.5
Evans, E.G.V.6
Hawkey, P.M.7
Herbrecht, R.8
Marks, D.I.9
Moraleda, J.M.10
Park, G.R.11
Senn, S.J.12
Viscoli, C.13
-
42
-
-
72849130455
-
Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis
-
Sun HY, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, et al. Lipid formulations of amphotericin B significantly improve outcome in solid organ transplant recipients with central nervous system cryptococcosis. Clin Infect Dis. 2009;49:1721-8.
-
(2009)
Clin Infect Dis
, vol.49
, pp. 1721-1728
-
-
Sun, H.Y.1
Alexander, B.D.2
Lortholary, O.3
Dromer, F.4
Forrest, G.N.5
Lyon, G.M.6
-
43
-
-
29944435853
-
Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis
-
DOI 10.1128/AAC.50.1.113-120.2006
-
Schwarz P, Dromer F, Lortholary O, Dannaoui E. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis. Antimicrob Agents Chemother. 2006;50:113-20. (Pubitemid 43042910)
-
(2006)
Antimicrobial Agents and Chemotherapy
, vol.50
, Issue.1
, pp. 113-120
-
-
Schwarz, P.1
Dromer, F.2
Lortholary, O.3
Dannaoui, E.4
-
44
-
-
2542602231
-
Combination antifungal therapies for HIV-associated cryptococcal meningitis: A randomised trial
-
DOI 10.1016/S0140-6736(04)16301-0, PII S0140673604163010
-
Brouwer AE, Rajanuwong A, Chierakul W, Griffin GE, Larsen RA, White NJ, et al. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Lancet. 2004;363:1764-7. (Pubitemid 38698379)
-
(2004)
Lancet
, vol.363
, Issue.9423
, pp. 1764-1767
-
-
Brouwer, A.E.1
Rajanuwong, A.2
Chierakul, W.3
Griffin, G.E.4
Larsen, R.A.5
White, N.J.6
Harrison, T.S.7
-
45
-
-
0038025895
-
Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome
-
National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group
-
van der Horst CM, Saag MS, Cloud GA, Hamill RJ, Graybill JR, Sobel JD, et al. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med. 1997;337:15-21.
-
(1997)
N Engl J Med
, vol.337
, pp. 15-21
-
-
Van Der Horst, C.M.1
Saag, M.S.2
Cloud, G.A.3
Hamill, R.J.4
Graybill, J.R.5
Sobel, J.D.6
-
46
-
-
46249098244
-
High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: A randomized trial
-
DOI 10.1086/588792
-
Bicanic T, Wood R, Meintjes G, Rebe K, Brouwer A, Loyse A, et al. High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial. Clin Infect Dis. 2008;47:123-30. (Pubitemid 351920599)
-
(2008)
Clinical Infectious Diseases
, vol.47
, Issue.1
, pp. 123-130
-
-
Bicanic, T.1
Wood, R.2
Meintjes, G.3
Rebe, K.4
Brouwer, A.5
Loyse, A.6
Bekker, L.-G.7
Jaffar, S.8
Harrison, T.9
-
49
-
-
0028586812
-
Flucytosine + fluconazole association in the treatment of a murine experimental model of cryptococcosis
-
Bava AJ, Negroni R. Flucytosine + fluconazole association in the treatment of a murine experimental model of cryptococcosis. Rev Inst Med Trop Sao Paulo. 1994;36:551-4.
-
(1994)
Rev Inst Med Trop Sao Paulo
, vol.36
, pp. 551-554
-
-
Bava, A.J.1
Negroni, R.2
-
50
-
-
64549108540
-
Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures
-
Bicanic T, Brouwer AE, Meintjes G, Rebe K, Limmathurotsakul D, Chierakul W, et al. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures. AIDS. 2009;23:701-6.
-
(2009)
AIDS
, vol.23
, pp. 701-706
-
-
Bicanic, T.1
Brouwer, A.E.2
Meintjes, G.3
Rebe, K.4
Limmathurotsakul, D.5
Chierakul, W.6
-
51
-
-
0042708428
-
Use of ventriculoperitoneal shunts to treat uncontrollable intracranial hypertension in patients who have cryptococcal meningitis without hydrocephalus
-
Liliang PC, Liang CL, Chang WN, Lu K, Lu CH. Use of ventriculoperitoneal shunts to treat uncontrollable intracranial hypertension in patients who have cryptococcal meningitis without hydrocephalus. Clin Infect Dis. 2002;34: E64-8.
-
(2002)
Clin Infect Dis
, vol.34
-
-
Liliang, P.C.1
Liang, C.L.2
Chang, W.N.3
Lu, K.4
Lu, C.H.5
-
52
-
-
0033956545
-
Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis
-
The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups
-
Graybill JR, Sobel J, Saag M, van Der HC, Powderly W, Cloud G, et al. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis. The NIAID Mycoses Study Group and AIDS Cooperative Treatment Groups. Clin Infect Dis. 2000;30:47-54.
-
(2000)
Clin Infect Dis
, vol.30
, pp. 47-54
-
-
Graybill, J.R.1
Sobel, J.2
Saag, M.3
Van Der, H.C.4
Powderly, W.5
Cloud, G.6
-
53
-
-
0024995518
-
Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis
-
Chin T, Fong IW, Vandenbroucke A. Pharmacokinetics of fluconazole in serum and cerebrospinal fluid in a patient with AIDS and cryptococcal meningitis. Pharmacotherapy. 1990;10:305-7. (Pubitemid 20264612)
-
(1990)
Pharmacotherapy
, vol.10
, Issue.4
, pp. 305-307
-
-
Chin, T.1
Fong, I.W.2
Vandenbroucke, A.3
-
54
-
-
40449105146
-
Posaconazole: A broad-spectrum triazole antifungal agent
-
DOI 10.1086/523576
-
Nagappan V, Deresinski S. Reviews of anti-infective agents: posaconazole: a broad-spectrum triazole antifungal agent. Clin Infect Dis. 2007;45:1610-7. (Pubitemid 351411847)
-
(2007)
Clinical Infectious Diseases
, vol.45
, Issue.12
, pp. 1610-1617
-
-
Nagappan, V.1
Deresinski, S.2
-
55
-
-
63049099731
-
Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant
-
Bandettini R, Castagnola E, Calvillo M, Micalizzi C, Ravegnani M, Pescetto L, et al. Voriconazole for cryptococcal meningitis in children with leukemia or receiving allogeneic hemopoietic stem cell transplant. J Chemother. 2009;21:108-9.
-
(2009)
J Chemother
, vol.21
, pp. 108-109
-
-
Bandettini, R.1
Castagnola, E.2
Calvillo, M.3
Micalizzi, C.4
Ravegnani, M.5
Pescetto, L.6
-
56
-
-
66949141155
-
Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: Evidence-based evolving trends
-
Sun HY, Wagener MM, Singh N. Cryptococcosis in solid-organ, hematopoietic stem cell, and tissue transplant recipients: evidence-based evolving trends. Clin Infect Dis. 2009;48:1566-76.
-
(2009)
Clin Infect Dis
, vol.48
, pp. 1566-1576
-
-
Sun, H.Y.1
Wagener, M.M.2
Singh, N.3
-
57
-
-
20444401226
-
An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients
-
DOI 10.1086/430606
-
Singh N, Lortholary O, Alexander BD, Gupta KL, John GT, Pursell K, et al. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis. 2005;40:1756-61. (Pubitemid 40799944)
-
(2005)
Clinical Infectious Diseases
, vol.40
, Issue.12
, pp. 1756-1761
-
-
Singh, N.1
Lortholary, O.2
Alexander, B.D.3
Gupta, K.L.4
John, G.T.5
Pursell, K.6
Munoz, P.7
Klintmalm, G.B.8
Stosor, V.9
Del, B.R.10
Limaye, A.P.11
Somani, J.12
Lyon, M.13
Houston, S.14
House, A.A.15
Pruett, T.L.16
Orloff, S.17
Humar, A.18
Dowdy, L.19
Garcia-Diaz, J.20
Kalil, A.C.21
Fisher, R.A.22
Husain, S.23
more..
-
58
-
-
27744463359
-
Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome
-
DOI 10.1097/01.tp.0000180530.17683.02
-
Singh N, Lortholary O, Alexander BD, Gupta KL, John GT, Pursell K, et al. Allograft loss in renal transplant recipients with Cryptococcus neoformans associated immune reconstitution syndrome. Transplantation. 2005;80:1131-3. (Pubitemid 41611940)
-
(2005)
Transplantation
, vol.80
, Issue.8
, pp. 1131-1133
-
-
Singh, N.1
Lortholary, O.2
Alexander, B.D.3
Gupta, K.L.4
John, G.T.5
Pursell, K.6
Munoz, P.7
Klintmalm, G.B.8
Stosor, V.9
DelBusto, R.10
Limaye, A.P.11
Somani, J.12
Lyon, M.13
Houston, S.14
House, A.A.15
Pruett, T.L.16
Orloff, S.17
Humar, A.18
Dowdy, L.19
Garcia-Diaz, J.20
Fisher, R.A.21
Husain, S.22
more..
-
59
-
-
62949194986
-
Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals?
-
Pérez-Parra A, Muñoz P, Guinea J, Martín- Rabadán P, Guembe M, Bouza E. Is Candida colonization of central vascular catheters in non-candidemic, non-neutropenic patients an indication for antifungals? Intensive Care Med. 2009;35:707-12.
-
(2009)
Intensive Care Med
, vol.35
, pp. 707-712
-
-
Pérez-Parra, A.1
Muñoz, P.2
Guinea, J.3
Martín- Rabadán, P.4
Guembe, M.5
Bouza, E.6
-
60
-
-
0033801252
-
Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America
-
Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, et al. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis. 2000;30:710-8.
-
(2000)
Clin Infect Dis
, vol.30
, pp. 710-718
-
-
Saag, M.S.1
Graybill, R.J.2
Larsen, R.A.3
Pappas, P.G.4
Perfect, J.R.5
Powderly, W.G.6
-
61
-
-
0029075535
-
Epidemiology of nosocomial fungal infections, with emphasis on Candida species
-
Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis. 1995;20:1526-30.
-
(1995)
Clin Infect Dis
, vol.20
, pp. 1526-1530
-
-
Jarvis, W.R.1
-
62
-
-
72249087115
-
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
-
Vincent JL, Rello J, Marshall J, Silva E, Anzueto A, Martin CD, et al. International Study of the Prevalence and Outcomes of Infection in Intensive Care Units. JAMA. 2009;302:2323-9.
-
(2009)
JAMA
, vol.302
, pp. 2323-2329
-
-
Vincent, J.L.1
Rello, J.2
Marshall, J.3
Silva, E.4
Anzueto, A.5
Martin, C.D.6
-
63
-
-
0242323689
-
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
-
DOI 10.1016/S1473-3099(03)00801-6
-
Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis. 2003;3:685-702. (Pubitemid 37345347)
-
(2003)
Lancet Infectious Diseases
, vol.3
, Issue.11
, pp. 685-702
-
-
Eggimann, P.1
Garbino, J.2
Pittet, D.3
-
64
-
-
61349151676
-
Fungal colonization and/or infection in non-neutropenic critically ill patients: Results of the EPCAN observational study
-
León C, Álvarez-Lerma F, Ruiz-Santana S, León MA, Nolla J, Jorda R, et al. Fungal colonization and/or infection in non-neutropenic critically ill patients: results of the EPCAN observational study. Eur J Clin Microbiol Infect Dis. 2009;28:233-42.
-
(2009)
Eur J Clin Microbiol Infect Dis
, vol.28
, pp. 233-242
-
-
León, C.1
Álvarez-Lerma, F.2
Ruiz-Santana, S.3
León, M.A.4
Nolla, J.5
Jorda, R.6
-
65
-
-
67650486324
-
Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: A prospective multicenter study
-
León C, Ruiz-Santana S, Saavedra P, Galván B, Blanco A, Castro C, et al. Usefulness of the "Candida score" for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med. 2009;37:1624-33.
-
(2009)
Crit Care Med
, vol.37
, pp. 1624-1633
-
-
León, C.1
Ruiz-Santana, S.2
Saavedra, P.3
Galván, B.4
Blanco, A.5
Castro, C.6
-
66
-
-
67650508061
-
Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005-2006)
-
Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, et al. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: A multicenter, prospective, observational study in France (2005-2006). Crit Care Med. 2009;37:1612-8.
-
(2009)
Crit Care Med
, vol.37
, pp. 1612-1618
-
-
Leroy, O.1
Gangneux, J.P.2
Montravers, P.3
Mira, J.P.4
Gouin, F.5
Sollet, J.P.6
-
67
-
-
69049100062
-
Determinants of mortality in non-neutropenic ICU patients with candidaemia
-
Marriott D, Playford EG, Chen S, Slavin M, Nguyen Q, Ellis D, et al. Determinants of mortality in non-neutropenic ICU patients with candidaemia. Critical Care. 2009;13:R115.
-
(2009)
Critical Care
, vol.13
-
-
Marriott, D.1
Playford, E.G.2
Chen, S.3
Slavin, M.4
Nguyen, Q.5
Ellis, D.6
-
68
-
-
64749108109
-
Temporal trends, risk factors and outcomes in albicans and non-albicans candidaemia: An international epidemiological study in four multidisciplinary intensive care units
-
Holley A, Dulhunty J, Blot S, Lipman J, Lobo S, Dancer C, et al. Temporal trends, risk factors and outcomes in albicans and non-albicans candidaemia: an international epidemiological study in four multidisciplinary intensive care units. Int J Antimicrob Agents. 2009;33:554.e1-7.
-
(2009)
Int J Antimicrob Agents
, vol.33
-
-
Holley, A.1
Dulhunty, J.2
Blot, S.3
Lipman, J.4
Lobo, S.5
Dancer, C.6
-
69
-
-
0033047638
-
Fluconazole prophylaxis prevents intra-abdominal candidiasis in high- risk surgical patients
-
DOI 10.1097/00003246-199906000-00019
-
Eggimann P, Francioli P, Bille J, Schneider R, Wu MM, Chapuis G, et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med. 1999;27:1066-72. (Pubitemid 29314312)
-
(1999)
Critical Care Medicine
, vol.27
, Issue.6
, pp. 1066-1072
-
-
Eggimann, P.1
Francioli, P.2
Bille, J.3
Schneider, R.4
Wu, M.-M.5
Chapuis, G.6
Chiolero, R.7
Pannatier, A.8
Schilling, J.9
Geroulanos, S.10
Glauser, M.P.11
Calandra, T.12
-
70
-
-
0035080325
-
Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically III surgical patients
-
DOI 10.1097/00000658-200104000-00010
-
Pelz RK, Hendrix CW, Swoboda SM, Diener-West M, Merz WG, Hammond J, et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg. 2001;233:542-8. (Pubitemid 32234953)
-
(2001)
Annals of Surgery
, vol.233
, Issue.4
, pp. 542-548
-
-
Pelz, R.K.1
Hendrix, C.W.2
Swoboda, S.M.3
Diener-West, M.4
Merz, W.G.5
Hammond, J.6
Lipsett, P.A.7
-
71
-
-
0036453937
-
Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination
-
Garbino J, Lew DP, Romand JA, Hugonnet S, Auckenthaler R, Pittet D. Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med. 2002;28:1708-17.
-
(2002)
Intensive Care Med
, vol.28
, pp. 1708-1717
-
-
Garbino, J.1
Lew, D.P.2
Romand, J.A.3
Hugonnet, S.4
Auckenthaler, R.5
Pittet, D.6
-
72
-
-
10644283859
-
Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients
-
DOI 10.1097/01.CCM.0000147726.62304.7F
-
Piarroux R, Grenouillet F, Balvay P, Tran V, Blasco G, Millon L, et al. Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med. 2004;32:2443-9. (Pubitemid 39648226)
-
(2004)
Critical Care Medicine
, vol.32
, Issue.12
, pp. 2443-2449
-
-
Piarroux, R.1
Grenouillet, F.2
Balvay, P.3
Tran, V.4
Blasco, G.5
Millon, L.6
Boillot, A.7
-
73
-
-
27744480105
-
Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: A systematic review and meta-analysis
-
DOI 10.1007/s00134-005-2794-y
-
Cruciani M, de Lalla F, Mengoli C. Prophylaxis of Candida infections in adult trauma and surgical intensive care patients: a systematic review and meta-analysis. Intensive Care Med. 2005;31:1479-87. (Pubitemid 41598657)
-
(2005)
Intensive Care Medicine
, vol.31
, Issue.11
, pp. 1479-1487
-
-
Cruciani, M.1
De Lalla, F.2
Mengoli, C.3
-
74
-
-
33645124177
-
Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: Systematic review and meta-analysis of randomized clinical trials
-
Playford EG, Webster AC, Sorrell TC, Craig JC. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials. J Antimicrob Chemother. 2006;57:628-38.
-
(2006)
J Antimicrob Chemother
, vol.57
, pp. 628-638
-
-
Playford, E.G.1
Webster, A.C.2
Sorrell, T.C.3
Craig, J.C.4
-
75
-
-
33645833237
-
Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: A meta-analysis of randomized, placebo-controlled trials
-
Vardakas KZ, Samonis G, Michalopoulos A, Soteriades ES, Falagas ME. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials. Crit Care Med. 2006;34:1216-24.
-
(2006)
Crit Care Med
, vol.34
, pp. 1216-1224
-
-
Vardakas, K.Z.1
Samonis, G.2
Michalopoulos, A.3
Soteriades, E.S.4
Falagas, M.E.5
-
76
-
-
0027942475
-
Candida colonization and subsequent infections in critically ill surgical patients
-
Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Ann Surg. 1994;220:751-8. (Pubitemid 24376373)
-
(1994)
Annals of Surgery
, vol.220
, Issue.6
, pp. 751-758
-
-
Pittet, D.1
Monod, M.2
Suter, P.M.3
Frenk, E.4
Auckenthaler, R.5
-
77
-
-
0028046352
-
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia
-
DOI 10.1056/NEJM199411173312001
-
Rex JH, Bennett JE, Sugar AM, Pappas PG, van der Horst CM, Edwards JE, et al. A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia. N Engl J Med. 1994;331:1325-30. (Pubitemid 24347001)
-
(1994)
New England Journal of Medicine
, vol.331
, Issue.20
, pp. 1325-1330
-
-
Rex, J.H.1
Bennett, J.E.2
Sugar, A.M.3
Pappas, P.G.4
Van Der, H.C.M.5
Edwards, J.E.6
Washburn, R.G.7
Scheld, W.M.8
Karchmer, A.W.9
Dine, A.P.10
Levenstein, M.J.11
Douglas, W.C.12
-
78
-
-
34548474329
-
Invasive candidiasis treated in the intensive care unit: Observations from a randomized clinical trial
-
DOI 10.1016/j.jcrc.2006.11.004, PII S0883944106002000
-
DiNubile MJ, Lupinacci RJ, Strohmaier KM, Sable CA, Kartsonis NA. Invasive candidiasis treated in the intensive care unit: Observations from a randomized clinical trial. J Crit Care. 2007;22:237-44. (Pubitemid 47380232)
-
(2007)
Journal of Critical Care
, vol.22
, Issue.3
, pp. 237-244
-
-
DiNubile, M.J.1
Lupinacci, R.J.2
Strohmaier, K.M.3
Sable, C.A.4
Kartsonis, N.A.5
-
79
-
-
77954720403
-
A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients
-
Hsu DI, Nguyen M, Nguyen L, Law A, Wong-Beringer A. A multicentre study to evaluate the impact of timing of caspofungin administration on outcomes of invasive candidiasis in non-immunocompromised adult patients. J Antimicrob Chemother. 2010;65:1765-70.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 1765-1770
-
-
Hsu, D.I.1
Nguyen, M.2
Nguyen, L.3
Law, A.4
Wong-Beringer, A.5
-
80
-
-
77950327388
-
Candida spp. bloodstream infection: Influence of antifungal treatment on outcome
-
Ortega M, Marco F, Soriano A, Almela M, Martínez JA, Pitart C, et al. Candida spp. bloodstream infection: influence of antifungal treatment on outcome. J Antimicrob Chemother. 2010;65:562-8.
-
(2010)
J Antimicrob Chemother
, vol.65
, pp. 562-568
-
-
Ortega, M.1
Marco, F.2
Soriano, A.3
Almela, M.4
Martínez, J.A.5
Pitart, C.6
-
81
-
-
32344436774
-
Triazole cross-resistance among Candida spp.: Case report, occurrence among bloodstream isolates, and implications for antifungal therapy
-
DOI 10.1128/JCM.44.2.529-535.2006
-
Magill SS, Shields C, Sears CL, Choti M, Merz WG. Triazole Cross-Resistance among Candida spp.: Case Report, Occurrence among Bloodstream Isolates, and Implications for Antifungal Therapy. J Clin Microbiol. 2006;44:529-35. (Pubitemid 43222248)
-
(2006)
Journal of Clinical Microbiology
, vol.44
, Issue.2
, pp. 529-535
-
-
Magill, S.S.1
Shields, C.2
Sears, C.L.3
Choti, M.4
Merz, W.G.5
-
82
-
-
0031035533
-
Candidemia in non-neutropenic critically ill patients: Analysis of prognostic factors and assessment of systemic antifungal therapy
-
Study Group of Fungal Infection in the ICU
-
Nolla-Salas J, Sitges-Serra A, León-Gil C, Martínez- González J, León-Regidor MA, Ibanez-Lucia P, et al. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. Intensive Care Med. 1997;23:23-30.
-
(1997)
Intensive Care Med
, vol.23
, pp. 23-30
-
-
Nolla-Salas, J.1
Sitges-Serra, A.2
León-Gil, C.3
Martínez- González, J.4
León-Regidor, M.A.5
Ibanez-Lucia, P.6
-
83
-
-
24144483474
-
Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained: A potential risk factor for hospital mortality
-
DOI 10.1128/AAC.49.9.3640-3645.2005
-
Morrell M, Fraser VJ, Kollef MH. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob Agents Chemother. 2005;49:3640-5. (Pubitemid 41233011)
-
(2005)
Antimicrobial Agents and Chemotherapy
, vol.49
, Issue.9
, pp. 3640-3645
-
-
Morrell, M.1
Fraser, V.J.2
Kollef, M.H.3
-
84
-
-
33745313876
-
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study
-
DOI 10.1086/504810
-
Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, et al. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study. Clin Infect Dis. 2006;43:25-31. (Pubitemid 43939072)
-
(2006)
Clinical Infectious Diseases
, vol.43
, Issue.1
, pp. 25-31
-
-
Garey, K.W.1
Rege, M.2
Pai, M.P.3
Mingo, D.E.4
Suda, K.J.5
Turpin, R.S.6
Bearden, D.T.7
-
85
-
-
34548138992
-
Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections
-
DOI 10.1093/jac/dkm212
-
Parkins MD, Sabuda DM, Elsayed S, Laupland KB. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother. 2007;60:613-8. (Pubitemid 47299877)
-
(2007)
Journal of Antimicrobial Chemotherapy
, vol.60
, Issue.3
, pp. 613-618
-
-
Parkins, M.D.1
Sabuda, D.M.2
Elsayed, S.3
Laupland, K.B.4
-
86
-
-
33646826630
-
Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004
-
Fridkin SK, Kaufman D, Edwards JR, Shetty S, Horan T. Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004. Pediatrics. 2006;117:1680-7.
-
(2006)
Pediatrics
, vol.117
, pp. 1680-1687
-
-
Fridkin, S.K.1
Kaufman, D.2
Edwards, J.R.3
Shetty, S.4
Horan, T.5
-
87
-
-
18444388276
-
Late-onset sepsis in very low birth weight neonates: The experience of the NICHD Neonatal Research Network
-
DOI 10.1542/peds.110.2.285
-
Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(2 Pt 1):285-91. (Pubitemid 34833012)
-
(2002)
Pediatrics
, vol.110
, Issue.2 I
, pp. 285-291
-
-
Stoll, B.J.1
Hansen, N.2
Fanaroff, A.A.3
Wright, L.L.4
Carlo, W.A.5
Ehrenkranz, R.A.6
Lemons, J.A.7
Donovan, E.F.8
Stark, A.R.9
Tyson, J.E.10
Oh, W.11
Bauer, C.R.12
Korones, S.B.13
Shankaran, S.14
Laptook, A.R.15
Stevenson, D.K.16
Papile, L.-A.17
Kenneth, P.W.18
-
88
-
-
0035665848
-
Risk factors for Candida species colonization of neonatal intensive care unit patients
-
DOI 10.1097/00006454-200112000-00005
-
Saiman L, Ludington E, Dawson JD, Patterson JE, Rangel-Frausto S, Wiblin RT, et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J. 2001;20:1119-24. (Pubitemid 34016422)
-
(2001)
Pediatric Infectious Disease Journal
, vol.20
, Issue.12
, pp. 1119-1124
-
-
Saiman, L.1
Ludington, E.2
Dawson, J.D.3
Patterson, J.E.4
Rangel-Frausto, S.5
Wiblin, R.T.6
Blumberg, H.M.7
Pfaller, M.8
Rinaldi, M.9
Edwards, J.E.10
Wenzel, R.P.11
Jarvis, W.12
Costigan, M.13
Neu, H.14
Martin, M.15
Webb, D.16
-
89
-
-
0037306019
-
Candida infections in the neonate
-
DOI 10.1097/00008480-200302000-00016
-
Chapman RL. Candida infections in the neonate. Curr Opin Pediatr. 2003;15:97-102. (Pubitemid 36132624)
-
(2003)
Current Opinion in Pediatrics
, vol.15
, Issue.1
, pp. 97-102
-
-
Chapman, R.L.1
-
90
-
-
33644911531
-
Candidemia in neonatal intensive care units: Barcelona, Spain
-
DOI 10.1097/01.inf.0000202127.43695.06, PII 0000645420060300000011
-
Rodríguez D, Almirante B, Park BJ, Cuenca-Estrella M, Planes AM, Sanchez F, et al. Candidemia in neonatal intensive care units: Barcelona. Spain Pediatr Infect Dis J. 2006;25:224-9. (Pubitemid 43379062)
-
(2006)
Pediatric Infectious Disease Journal
, vol.25
, Issue.3
, pp. 224-229
-
-
Rodriguez, D.1
Almirante, B.2
Park, B.J.3
Cuenca-Estrella, M.4
Planes, A.M.5
Sanchez, F.6
Gene, A.7
Xercavins, M.8
Fontanals, D.9
Rodriguez-Tudela, J.L.10
Warnock, D.W.11
Pahissa, A.12
-
91
-
-
0038653542
-
Neonatal invasive candidiasis: A prospective multicenter study of 118 cases
-
DOI 10.1055/s-2003-40008
-
López Sastre JB, Coto Cotallo GD, Fernández Colomer B, Grupo de Hospitales Castrillo. Neonatal invasive candidiasis: a prospective multicenter study of 118 cases. Am J Perinatol. 2003;20:153-63. (Pubitemid 36682311)
-
(2003)
American Journal of Perinatology
, vol.20
, Issue.3
, pp. 153-163
-
-
Lopez, S.J.B.1
Coto, C.G.D.2
Fernandez, C.B.3
-
93
-
-
33748427541
-
The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants
-
National Institute for Child Health and Human Development Neonatal Research Network
-
Cotten CM, McDonald S, Stoll B, Goldberg RN, Poole K, Benjamin Jr DK, National Institute for Child Health and Human Development Neonatal Research Network. The association of third-generation cephalosporin use and invasive candidiasis in extremely low birth-weight infants. Pediatrics. 2006;118:717-22.
-
(2006)
Pediatrics
, vol.118
, pp. 717-722
-
-
Cotten, C.M.1
McDonald, S.2
Stoll, B.3
Goldberg, R.N.4
Poole, K.5
Benjamin Jr., D.K.6
-
94
-
-
33746707591
-
Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth
-
DOI 10.1097/01.inf.0000226978.96218.e6, PII 0000645420060800000013
-
Kaufman DA, Gurka MJ, Hazen KC, Boyle R, Robinson M, Grossman LB. Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth. Pediatr Infect Dis J. 2006;25:733-7. (Pubitemid 44162132)
-
(2006)
Pediatric Infectious Disease Journal
, vol.25
, Issue.8
, pp. 733-737
-
-
Kaufman, D.A.1
Gurka, M.J.2
Hazen, K.C.3
Boyle, R.4
Robinson, M.5
Grossman, L.B.6
-
95
-
-
0034001629
-
Risk factors for candidemia in Neonatal Intensive Care Unit patients
-
The National Epidemiology of Mycosis Survey study group
-
Saiman L, Ludington E, Pfaller M, Rangel-Frausto S, Wiblin RT, Dawson J, et al. Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group. Pediatr Infect Dis J. 2000;19:319-24.
-
(2000)
Pediatr Infect Dis J
, vol.19
, pp. 319-324
-
-
Saiman, L.1
Ludington, E.2
Pfaller, M.3
Rangel-Frausto, S.4
Wiblin, R.T.5
Dawson, J.6
-
96
-
-
33644836691
-
Neonatal candidiasis among extremely low birth weight infants: Risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months
-
DOI 10.1542/peds.2004-2292
-
Benjamin Jr DK, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, et al. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics. 2006;117:84-92. (Pubitemid 46050523)
-
(2006)
Pediatrics
, vol.117
, Issue.1
, pp. 84-92
-
-
Benjamin Jr., D.K.1
Stoll, B.J.2
Fanaroff, A.A.3
McDonald, S.A.4
Oh, W.5
Higgins, R.D.6
Duara, S.7
Poole, K.8
Laptook, A.9
Goldberg, R.10
-
97
-
-
0034322385
-
Should central venous catheters be removed as soon as candidemia is detected in neonates?
-
Karlowicz MG, Hashimoto LN, Kelly Jr RE, Buescher ES. Should central venous catheters be removed as soon as candidemia is detected in neonates? Pediatrics. 2000;106:E63.
-
(2000)
Pediatrics
, vol.106
-
-
Karlowicz, M.G.1
Hashimoto, L.N.2
Kelly Jr., R.E.3
Buescher, E.S.4
-
98
-
-
0033829973
-
Persistently positive cultures and outcome in invasive neonatal candidiasis
-
Chapman RL, Faix RG. Persistently positive cultures and outcome in invasive neonatal candidiasis. Pediatr Infect Dis J. 2000;19:822-7.
-
(2000)
Pediatr Infect Dis J
, vol.19
, pp. 822-827
-
-
Chapman, R.L.1
Faix, R.G.2
-
99
-
-
19544369842
-
Antifungal agents in children
-
DOI 10.1016/j.pcl.2005.02.009, PII S0031395505000362, Pediatric Infectious Diseases
-
Steinbach WJ. Antifungal agents in children. Pediatr Clin North Am. 2005;52:895-915. (Pubitemid 40733599)
-
(2005)
Pediatric Clinics of North America
, vol.52
, Issue.3
, pp. 895-915
-
-
Steinbach, W.J.1
-
100
-
-
35048877533
-
Antifungal agents in neonates: Issues and recommendations
-
Almirante B, Rodríguez D. Antifungal agents in neonates: issues and recommendations. Paediatr Drugs. 2007;9:311-21. (Pubitemid 47557113)
-
(2007)
Pediatric Drugs
, vol.9
, Issue.5
, pp. 311-321
-
-
Almirante, B.1
Rodriguez, D.2
-
101
-
-
77956163311
-
Candidiasis
-
American Academy of Pediatrics. Pickering, L.K., editor. Elk Grove Village, IL: American Academy of Pediatrics
-
American Academy of Pediatrics. Candidiasis. En: Pickering, L.K., editor. Red Book: 2009 Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2009.p.245-253.
-
(2009)
Red Book: 2009 Report of the Committee on Infectious Diseases
, pp. 245-253
-
-
-
102
-
-
60549098868
-
Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America
-
Pappas PG, Kauffman CA, Andes D, Benjamin Jr DK, Calandra TF, Edwards Jr JE, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503-35.
-
(2009)
Clin Infect Dis
, vol.48
, pp. 503-535
-
-
Pappas, P.G.1
Kauffman, C.A.2
Andes, D.3
Benjamin Jr., D.K.4
Calandra, T.F.5
Edwards Jr., J.E.6
-
103
-
-
0023361099
-
Amphotericin B dosage for disseminated candidiasis in premature infants
-
Hall JE, Cox F, Karlson K, Robertson A. Amphotericin B dosage for disseminated candidiasis in premature infants. J Perinatol. 1987;7:194-8.
-
(1987)
J Perinatol
, vol.7
, pp. 194-198
-
-
Hall, J.E.1
Cox, F.2
Karlson, K.3
Robertson, A.4
-
105
-
-
0025357278
-
Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates
-
DOI 10.1016/S0022-3476(05)82674-5
-
Baley JE, Meyers C, Kliegman RM, Jacobs MR, Blumer JL. Pharmacokinetics, outcome of treatment, and toxic effects of amphotericin B and 5-fluorocytosine in neonates. J Pediatr. 1990;116:791-7. (Pubitemid 20162837)
-
(1990)
Journal of Pediatrics
, vol.116
, Issue.5
, pp. 791-797
-
-
Baley, J.E.1
Meyers, C.2
Kliegman, R.M.3
Jacobs, M.R.4
Blumer, J.L.5
-
106
-
-
0031737609
-
Management of neonatal candidiasis
-
Neonatal Candidiasis Study Group
-
Rowen JL, Tate JM. Management of neonatal candidiasis. Neonatal Candidiasis Study Group. Pediatr Infect Dis J. 1998;17:1007-11.
-
(1998)
Pediatr Infect Dis J
, vol.17
, pp. 1007-1011
-
-
Rowen, J.L.1
Tate, J.M.2
-
107
-
-
0025262116
-
Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates
-
Butler KM, Rench MA, Baker CJ. Amphotericin B as a single agent in the treatment of systemic candidiasis in neonates. Pediatr Infect Dis J. 1990;9: 51-6.
-
(1990)
Pediatr Infect Dis J
, vol.9
, pp. 51-56
-
-
Butler, K.M.1
Rench, M.A.2
Baker, C.J.3
-
108
-
-
0030765063
-
Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis
-
Walsh TJ, Whitcomb P, Piscitelli S, Figg WD, Hill S, Chanock SJ, et al. Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis. Antimicrob Agents Chemother. 1997;41:1944-8. (Pubitemid 27383233)
-
(1997)
Antimicrobial Agents and Chemotherapy
, vol.41
, Issue.9
, pp. 1944-1948
-
-
Walsh, T.J.1
Whitcomb, P.2
Piscitelli, S.3
Figg, W.D.4
Hill, S.5
Chanock, S.J.6
Jarosinski, P.7
Gupta, R.8
Pizzo, P.A.9
-
109
-
-
0032806739
-
Amphotericin B lipid complex in pediatric patients with invasive fungal infections
-
DOI 10.1097/00006454-199908000-00010
-
Walsh TJ, Seibel NL, Arndt C, Harris RE, Dinubile MJ, Reboli A, et al. Amphotericin B lipid complex in pediatric patients with invasive fungal infections. Pediatr Infect Dis J. 1999;18:702-8. (Pubitemid 29382466)
-
(1999)
Pediatric Infectious Disease Journal
, vol.18
, Issue.8
, pp. 702-708
-
-
Walsh, T.J.1
Seibel, N.L.2
Arndt, C.3
Harris, R.E.4
Dinubile, M.J.5
Reboli, A.6
Hiemenz, J.7
Chanock, S.J.8
-
110
-
-
0031950695
-
Liposomal amphotericin B treatment for neonatal fungal infections
-
DOI 10.1097/00006454-199802000-00013
-
Scarcella A, Pasquariello MB, Giugliano B, Vendemmia M, de Lucia A. Liposomal amphotericin B treatment for neonatal fungal infections. Pediatr Infect Dis J. 1998;17:146-8. (Pubitemid 28096014)
-
(1998)
Pediatric Infectious Disease Journal
, vol.17
, Issue.2
, pp. 146-148
-
-
Scarcella, A.1
Pasquariello, M.B.2
Giugliano, B.3
Vendemmia, M.4
De Lucia, A.5
-
111
-
-
0242298141
-
High-Dose Liposomal Amphotericin B in the Therapy of Systemic Candidiasis in Neonates
-
DOI 10.1007/s10096-003-0993-4
-
Juster-Reicher A, Flidel-Rimon O, Amitay M, Even-Tov S, Shinwell E, Leibovitz E. High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates. Eur J Clin Microbiol Infect Dis. 2003;22:603-7. (Pubitemid 37363539)
-
(2003)
European Journal of Clinical Microbiology and Infectious Diseases
, vol.22
, Issue.10
, pp. 603-607
-
-
Juster-Reicher, A.1
Flidel-Rimon, O.2
Amitay, M.3
Even-Tov, S.4
Shinwell, E.5
Leibovitz, E.6
-
112
-
-
0026574215
-
Safety and pharmacokinetics of fluconazole in children with neoplastic diseases
-
Lee JW, Seibel NL, Amantea M, Whitcomb P, Pizzo PA, Walsh TJ. Safety and pharmacokinetics of fluconazole in children with neoplastic diseases. J Pediatr. 1992;120:987-93.
-
(1992)
J Pediatr
, vol.120
, pp. 987-993
-
-
Lee, J.W.1
Seibel, N.L.2
Amantea, M.3
Whitcomb, P.4
Pizzo, P.A.5
Walsh, T.J.6
-
113
-
-
0027437498
-
Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life
-
Saxen H, Hoppu K, Pohjavuori M. Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life. Clin Pharmacol Ther. 1993;54:269-77. (Pubitemid 23294527)
-
(1993)
Clinical Pharmacology and Therapeutics
, vol.54
, Issue.3
, pp. 269-277
-
-
Saxen, H.1
Hoppu, K.2
Pohjavuori, M.3
-
114
-
-
0028795288
-
Pharmacokinetics of fluconazole in immune-compromised children with leukemia or other hematologic diseases
-
Seay RE, Larson TA, Toscano JP, Bostrom BC, O'Leary MC, Uden DL. Pharmacokinetics of fluconazole in immune-compromised children with leukemia or other hematologic diseases. Pharmacotherapy. 1995;15:52-8.
-
(1995)
Pharmacotherapy
, vol.15
, pp. 52-58
-
-
Seay, R.E.1
Larson, T.A.2
Toscano, J.P.3
Bostrom, B.C.4
O'Leary, M.C.5
Uden, D.L.6
-
115
-
-
55849102471
-
Population pharmacokinetics of fluconazole in young infants
-
Wade KC, Wu D, Kaufman DA, Ward RM, Benjamin Jr DK, Sullivan JE, et al. Population pharmacokinetics of fluconazole in young infants. Antimicrob Agents Chemother. 2008;52:4043-9.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 4043-4049
-
-
Wade, K.C.1
Wu, D.2
Kaufman, D.A.3
Ward, R.M.4
Benjamin Jr., D.K.5
Sullivan, J.E.6
-
116
-
-
68649095708
-
Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants
-
Wade KC, Benjamin Jr DK, Kaufman DA, Ward RM, Smith PB, Jayaraman B, et al. Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants. Pediatr Infect Dis J. 2009;28:717-23.
-
(2009)
Pediatr Infect Dis J
, vol.28
, pp. 717-723
-
-
Wade, K.C.1
Benjamin Jr., D.K.2
Kaufman, D.A.3
Ward, R.M.4
Smith, P.B.5
Jayaraman, B.6
-
117
-
-
0030457165
-
Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: A prospective randomized trial
-
DOI 10.1097/00006454-199612000-00011
-
Driessen M, Ellis JB, Cooper PA, Wainer S, Muwazi F, Hahn D, et al. Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial. Pediatr Infect Dis J. 1996;15:1107-12. (Pubitemid 27014703)
-
(1996)
Pediatric Infectious Disease Journal
, vol.15
, Issue.12
, pp. 1107-1112
-
-
Driessen, M.1
Ellis, J.B.2
Cooper, P.A.3
Wainer, S.4
Muwazi, F.5
Hahn, D.6
Gous, H.7
De Villiers, F.P.R.8
-
118
-
-
0141928536
-
Treatment of candidaemia in premature infants: Comparison of three amphotericin B preparations
-
DOI 10.1093/jac/dkg419
-
Linder N, Klinger G, Shalit I, Levy I, Ashkenazi S, Haski G, et al. Treatment of candidaemia in premature infants: comparison of three amphotericin B preparations. J Antimicrob Chemother. 2003;52:663-7. (Pubitemid 37258429)
-
(2003)
Journal of Antimicrobial Chemotherapy
, vol.52
, Issue.4
, pp. 663-667
-
-
Linder, N.1
Klinger, G.2
Shalit, I.3
Levy, I.4
Ashkenazi, S.5
Haski, G.6
Levit, O.7
Sirota, L.8
-
119
-
-
28844463918
-
Population pharmacokinetics of amphotericin B lipid complex in neonates
-
DOI 10.1128/AAC.49.12.5092-5098.2005
-
Würthwein G, Groll AH, Hempel G, Adler-Shohet FC, Lieberman JM, Walsh TJ. Population pharmacokinetics of amphotericin B lipid complex in neonates. Antimicrob Agents Chemother. 2005;49:5092-8. (Pubitemid 41778925)
-
(2005)
Antimicrobial Agents and Chemotherapy
, vol.49
, Issue.12
, pp. 5092-5098
-
-
Wurthwein, G.1
Groll, A.H.2
Hempel, G.3
Adler-Shohet, F.C.4
Lieberman, J.M.5
Walsh, T.J.6
-
121
-
-
23044445767
-
Safety, tolerability, and pharmacokinetics of micafungin (FK463) in febrile neutropenic pediatric patients
-
DOI 10.1128/AAC.49.8.3317-3324.2005
-
Seibel NL, Schwartz C, Arrieta A, Flynn P, Shad A, Albano E, et al. Safety, tolerability, and pharmacokinetics of Micafungin (FK463) in febrile neutropenic pediatric patients. Antimicrob Agents Chemother. 2005;49:3317-24. (Pubitemid 41060577)
-
(2005)
Antimicrobial Agents and Chemotherapy
, vol.49
, Issue.8
, pp. 3317-3324
-
-
Seibel, N.L.1
Schwartz, C.2
Arrieta, A.3
Flynn, P.4
Shad, A.5
Albano, E.6
Keirns, J.7
Lau, W.M.8
Facklam, D.P.9
Buell, D.N.10
Walsh, T.J.11
-
122
-
-
33845412802
-
The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants
-
DOI 10.1097/01.inf.0000245103.07614.e1, PII 0000645420061200000004
-
Heresi GP, Gerstmann DR, Reed MD, van den Anker JN, Blumer JL, Kovanda L, et al. The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants. Pediatr Infect Dis J. 2006;25:1110-5. (Pubitemid 44900673)
-
(2006)
Pediatric Infectious Disease Journal
, vol.25
, Issue.12
, pp. 1110-1115
-
-
Heresi, G.P.1
Gerstmann, D.R.2
Reed, M.D.3
Van Den, A.J.N.4
Blumer, J.L.5
Kovanda, L.6
Keirns, J.J.7
Buell, D.N.8
Kearns, G.L.9
-
123
-
-
31944441962
-
Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections
-
DOI 10.1128/AAC.50.2.632-638.2006
-
Benjamin Jr DK, Driscoll T, Seibel NL, Gonzalez CE, Roden MM, Kilaru R, et al. Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections. Antimicrob Agents Chemother. 2006;50:632-8. (Pubitemid 43190976)
-
(2006)
Antimicrobial Agents and Chemotherapy
, vol.50
, Issue.2
, pp. 632-638
-
-
Benjamin Jr., D.K.1
Driscoll, T.2
Seibel, N.L.3
Gonzalez, C.E.4
Roden, M.M.5
Kilaru, R.6
Clark, K.7
Dowell, J.A.8
Schranz, J.9
Walsh, T.J.10
-
124
-
-
67649559611
-
Pharmacokinetics of an elevated dosage of micafungin in premature neonates
-
Smith PB, Walsh TJ, Hope W, Arrieta A, Takada A, Kovanda LL, et al. Pharmacokinetics of an elevated dosage of micafungin in premature neonates. Pediatr Infect Dis J. 2009;28:412-5.
-
(2009)
Pediatr Infect Dis J
, vol.28
, pp. 412-415
-
-
Smith, P.B.1
Walsh, T.J.2
Hope, W.3
Arrieta, A.4
Takada, A.5
Kovanda, L.L.6
-
125
-
-
27444432361
-
The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis
-
DOI 10.1086/496922
-
Zaoutis TE, Argon J, Chu J, Berlin JA, Waslsh TJ, Feudtner C. The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis. Clin Infect Dis. 2005;41:1232-9. (Pubitemid 41532664)
-
(2005)
Clinical Infectious Diseases
, vol.41
, Issue.9
, pp. 1232-1239
-
-
Zaoutis, T.E.1
Argon, J.2
Chu, J.3
Berlin, J.A.4
Walsh, T.J.5
Feudtner, C.6
-
126
-
-
0028950634
-
Candidemia in a pediatric population
-
Stamos JK, Rowley AH. Candidemia in a pediatric population. Clin Infect Dis. 1995;20:571-5.
-
(1995)
Clin Infect Dis
, vol.20
, pp. 571-575
-
-
Stamos, J.K.1
Rowley, A.H.2
-
127
-
-
66149142200
-
Not just little adults: Candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients
-
Blyth CC, Chen SC, Slavin MA, Serena C, Nguyen Q, Marriott D, et al. Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients. Pediatrics. 2009;123:1360-8.
-
(2009)
Pediatrics
, vol.123
, pp. 1360-1368
-
-
Blyth, C.C.1
Chen, S.C.2
Slavin, M.A.3
Serena, C.4
Nguyen, Q.5
Marriott, D.6
-
128
-
-
41849143805
-
Nosocomial candidaemia in children: Results of a 9-year study
-
DOI 10.1111/j.1439-0507.2007.01464.x
-
Celebi S, Hacimustafaoglu M, Ozdemir O, Ozkaya G. Nosocomial candidaemia in children: results of a 9-year study. Mycoses. 2008;51:248-57. (Pubitemid 351502573)
-
(2008)
Mycoses
, vol.51
, Issue.3
, pp. 248-257
-
-
Celebi, S.1
Hacimustafaoglu, M.2
Ozdemir, O.3
Ozkaya, G.4
-
129
-
-
58149373635
-
Pediatric antifungal utilization: New drugs, new trends
-
Prasad PA, Coffin SE, Leckerman KH, Walsh TJ, Zaoutis TE. Pediatric antifungal utilization: new drugs, new trends. Pediatr Infect Dis J. 2008;27:1083-8.
-
(2008)
Pediatr Infect Dis J
, vol.27
, pp. 1083-1088
-
-
Prasad, P.A.1
Coffin, S.E.2
Leckerman, K.H.3
Walsh, T.J.4
Zaoutis, T.E.5
-
130
-
-
34147174969
-
Antifungal therapy in children with invasive fungal infections: A systematic review
-
DOI 10.1542/peds.2006-2931
-
Blyth CC, Palasanthiran P, O'Brien TA. Antifungal therapy in children witn invasive fungal infections: a systematic review. Pediatrics. 2007;119:772-84. (Pubitemid 46556677)
-
(2007)
Pediatrics
, vol.119
, Issue.4
, pp. 772-784
-
-
Blyth, C.C.1
Palasanthiran, P.2
O'Brien, T.A.3
-
131
-
-
2542443542
-
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration
-
DOI 10.1128/AAC.48.6.2166-2172.2004
-
Walsh TJ, Karlsson MO, Driscoll T, Arguedas AG, Adamson P, Saez-Llorens
-
(2004)
Antimicrobial Agents and Chemotherapy
, vol.48
, Issue.6
, pp. 2166-2172
-
-
Walsh, T.J.1
Karlsson, M.O.2
Driscoll, T.3
Arguedas, A.G.4
Adamson, P.5
Saez-Llorens, X.6
Vora, A.J.7
Arrieta, A.C.8
Blumer, J.9
Lutsar, I.10
Milligan, P.11
Wood, N.12
-
132
-
-
62949105433
-
Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies
-
Karlsson MO, Lutsar I, Milligan PA. Population pharmacokinetic analysis of voriconazole plasma concentration data from pediatric studies. Antimicrob Agents Chemother. 2009;53:935-44.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 935-944
-
-
Karlsson, M.O.1
Lutsar, I.2
Milligan, P.A.3
-
133
-
-
72049130592
-
Voriconazole pharmacokinetics and pharmacodynamics in children
-
Neeley M, Rushing T, Kovacs A, Jellife R, Hoffman J. Voriconazole pharmacokinetics and pharmacodynamics in children. Clin Infect Dis. 2010;50:27-36.
-
(2010)
Clin Infect Dis
, vol.50
, pp. 27-36
-
-
Neeley, M.1
Rushing, T.2
Kovacs, A.3
Jellife, R.4
Hoffman, J.5
-
134
-
-
58149395905
-
Caspofungin for the treatment of pediatric fungal infections
-
Fisher BT, Zaoutis T. Caspofungin for the treatment of pediatric fungal infections. Pediatr Infect Dis J. 2008;27:1099-102.
-
(2008)
Pediatr Infect Dis J
, vol.27
, pp. 1099-1102
-
-
Fisher, B.T.1
Zaoutis, T.2
-
135
-
-
63149172257
-
A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients
-
Zaoutis TE, Jafri HS, Huang LM, Locatelli F, Barzilai A, Ebell W, et al. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients. Pediatrics. 2009;123:877-84.
-
(2009)
Pediatrics
, vol.123
, pp. 877-884
-
-
Zaoutis, T.E.1
Jafri, H.S.2
Huang, L.M.3
Locatelli, F.4
Barzilai, A.5
Ebell, W.6
-
136
-
-
53049099239
-
Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: Substudy of a randomized double-blind trial
-
Queiroz-Telles F, Berezin E, Leverger G, Freire A, van der Vyver A, Chotpitayasunondh T, et al. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Pediatr Infect Dis J. 2008;27:820-6.
-
(2008)
Pediatr Infect Dis J
, vol.27
, pp. 820-826
-
-
Queiroz-Telles, F.1
Berezin, E.2
Leverger, G.3
Freire, A.4
Van Der Vyver, A.5
Chotpitayasunondh, T.6
-
137
-
-
34147174969
-
Antifungal therapy in children with invasive fungal infections: A systematic review
-
DOI 10.1542/peds.2006-2931
-
Blyth CC, Palasanthiran P, O'Brien TA. Antifungal therapy in children with invasive fungal infections: a systematic review. Pediatrics. 2007;119:772-84. (Pubitemid 46556677)
-
(2007)
Pediatrics
, vol.119
, Issue.4
, pp. 772-784
-
-
Blyth, C.C.1
Palasanthiran, P.2
O'Brien, T.A.3
-
138
-
-
0028222208
-
Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients
-
Presterl E, Graninger W. Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients. Multicentre Study Group. Eur J Clin Microbiol Infect Dis. 1994;13:347-51. (Pubitemid 24139815)
-
(1994)
European Journal of Clinical Microbiology and Infectious Diseases
, vol.13
, Issue.4
, pp. 347-351
-
-
Presterl, E.1
Graninger, W.2
Brammer, K.W.3
Dopfer, R.4
Schmitt, H.J.5
Gadner, H.6
Zoubek, A.7
Robert, A.8
Rubie, H.9
Holzel, H.10
Bain, L.A.11
Macrae, D.J.12
Reinert, P.13
Vannier, J.P.14
Marguerite, C.15
Gouyon, J.B.16
Paolucci, G.17
Principi, N.18
-
139
-
-
0034704972
-
Treatment of candidal infections with fluconazole in neonates and infants
-
Schwarze R, Penk A, Pittrow L. Treatment of candidal infections with fluconazole in neonates and infants. Eur J Med Res. 2000;5:203-8.
-
(2000)
Eur J Med Res
, vol.5
, pp. 203-208
-
-
Schwarze, R.1
Penk, A.2
Pittrow, L.3
-
140
-
-
16644371770
-
Caspofungin therapy of neonates with invasive candidiasis
-
DOI 10.1097/01.inf.0000145408.51526.0a
-
Odio CM, Araya R, Pinto LE, Castro CE, Vasquez S, Alfaro B, et al. Caspofungin therapy of neonates with invasive candidiasis. Pediatr Infect Dis J. 2004;23:1093-7. (Pubitemid 40812754)
-
(2004)
Pediatric Infectious Disease Journal
, vol.23
, Issue.12
, pp. 1093-1097
-
-
Odio, C.M.1
Araya, R.2
Pinto, L.E.3
Castro, C.E.4
Vasquez, S.5
Alfaro, B.6
Saenz, A.7
Herrera, M.L.8
Walsh, T.J.9
-
141
-
-
33845443893
-
Efficacy and safety of caspofungin therapy in children with invasive fungal infections
-
DOI 10.1097/01.inf.0000246844.42159.a0, PII 0000645420061200000018
-
Merlin E, Galambrun C, Ribaud P, Blanc T, Michel G, Auvrignon A, et al. Efficacy and safety of caspofungin therapy in children with invasive fungal infections. Pediatr Infect Dis J. 2006;25:1186-8. (Pubitemid 44900687)
-
(2006)
Pediatric Infectious Disease Journal
, vol.25
, Issue.12
, pp. 1186-1188
-
-
Merlin, E.1
Galambrun, C.2
Ribaud, P.3
Blanc, T.4
Michel, G.5
Auvrignon, A.6
Stephan, J.-L.7
-
142
-
-
34548213289
-
Efficacy and safety of caspofungin for the empiric management of fever in neutropenic children
-
DOI 10.1097/INF.0b013e318067b4d1, PII 0000645420070900000020
-
Koo A, Sung L, Allen U, Naqvi A, Drynan-Arsenault J, Dekker A, et al. Efficacy and safety of caspofungin for the empiric management of fever in neutropenic children. Pediatr Infect Dis J. 2007;26:854-6. (Pubitemid 47329864)
-
(2007)
Pediatric Infectious Disease Journal
, vol.26
, Issue.9
, pp. 854-856
-
-
Koo, A.1
Sung, L.2
Allen, U.3
Naqvi, A.4
Drynan-Arsenault, J.5
Dekker, A.6
Maloney, A.M.7
Dupuis, L.L.8
-
143
-
-
48949119130
-
Voriconazole plasma monitoring
-
DOI 10.1136/adc.2007.118844
-
Pasqualotto AC, Shah M, Wynn R, Denning DW. Voriconazole plasma monitoring. Arch Dis Child. 2008;93:578-81. (Pubitemid 352030079)
-
(2008)
Archives of Disease in Childhood
, vol.93
, Issue.7
, pp. 578-581
-
-
Pasqualotto, A.C.1
Shah, M.2
Wynn, R.3
Denning, D.W.4
-
144
-
-
77951874577
-
A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia
-
Caspofungin Pediatric Study Group
-
Maertens JA, Madero L, Reilly AF, Lehrnbecher T, Groll AH, Jafri HS, et al., Caspofungin Pediatric Study Group. A randomized, double-blind, multicenter study of caspofungin versus liposomal amphotericin B for empiric antifungal therapy in pediatric patients with persistent fever and neutropenia. Pediatr Infect Dis J. 2010;29:415-20.
-
(2010)
Pediatr Infect Dis J
, vol.29
, pp. 415-420
-
-
Maertens, J.A.1
Madero, L.2
Reilly, A.F.3
Lehrnbecher, T.4
Groll, A.H.5
Jafri, H.S.6
-
145
-
-
0029788069
-
Cryptococcosis in human immunodeficiency virus-infected children
-
DOI 10.1097/00006454-199609000-00012
-
Gonzalez CE, Shetty D, Lewis LL, Mueller BU, Pizzo PA, Walsh TJ. Cryptococcosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1996;15:796-800. (Pubitemid 26304455)
-
(1996)
Pediatric Infectious Disease Journal
, vol.15
, Issue.9
, pp. 796-800
-
-
Gonzalez, C.E.1
Shetty, D.2
Lewis, L.L.3
Mueller, B.U.4
Pizzo, P.A.5
Walsh, T.J.6
-
147
-
-
0030908236
-
Liposomal amphotericin B and recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in the treatment of paediatric AIDS- related cryptococcosis
-
DOI 10.1258/0956462971920226
-
Manfredi R, Coronado OV, Mastroianni A, Chiodo F. Liposomal amphotericin B and recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in the treatment of paediatric AIDS-related cryptococcosis. Int J STD AIDS. 1997;8:406-8. (Pubitemid 27241483)
-
(1997)
International Journal of STD and AIDS
, vol.8
, Issue.6
, pp. 406-408
-
-
Manfredi, R.1
Coronado, O.V.2
Mastroianni, A.3
Chiodo, F.4
-
148
-
-
13844298286
-
Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections
-
Wiley JM, Seibel NL, Walsh TJ. Efficacy and safety of amphotericin B lipid complex in 548 children and adolescents with invasive fungal infections. Pediatr Infect Dis J. 2005;24:167-74.
-
(2005)
Pediatr Infect Dis J
, vol.24
, pp. 167-174
-
-
Wiley, J.M.1
Seibel, N.L.2
Walsh, T.J.3
-
149
-
-
75749092958
-
Clinical practice guidelines for the management of cryptococcal disease: 2010 Update by the Infectious Diseases Society of America
-
Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:291-322.
-
(2010)
Clin Infect Dis
, vol.50
, pp. 291-322
-
-
Perfect, J.R.1
Dismukes, W.E.2
Dromer, F.3
Goldman, D.L.4
Graybill, J.R.5
Hamill, R.J.6
-
150
-
-
5444272819
-
Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus
-
DOI 10.1128/JCM.42.10.4419-4431.2004
-
Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol. 2004;42:4419-31. (Pubitemid 39362350)
-
(2004)
Journal of Clinical Microbiology
, vol.42
, Issue.10
, pp. 4419-4431
-
-
Pfaller, M.A.1
Diekema, D.J.2
-
151
-
-
20144389929
-
Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: A restropective multicenter study from Italy and review of the literature
-
Girmenia C, Pagano L, Martino B, D'Antonio D, Fanci R, Specchia G, et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a restropective multicenter study from Italy and review of the literature. J Clin Microbiol. 2005;43: 1818-28.
-
(2005)
J Clin Microbiol
, vol.43
, pp. 1818-1828
-
-
Girmenia, C.1
Pagano, L.2
Martino, B.3
D'Antonio, D.4
Fanci, R.5
Specchia, G.6
-
152
-
-
0035046983
-
Trichosporon species infection in bone marrow transplanted patients
-
DOI 10.1016/S0732-8893(01)00215-2, PII S0732889301002152
-
Moretti-Branchini ML, Fukushima K, Schreiber AZ, Nishimura K, Papaiordanou PMO, Trabasso P, et al. Trichosporon species infection in bone marrow transplanted patients. Diagnost Microbiol Infect Dis. 2001;39:161-4. (Pubitemid 32406171)
-
(2001)
Diagnostic Microbiology and Infectious Disease
, vol.39
, Issue.3
, pp. 161-164
-
-
Moretti-Branchini, M.L.1
Fukushima, K.2
Schreiber, A.Z.3
Nishimura, K.4
Papaiordanou, P.M.O.5
Trabasso, P.6
Tanaka, R.7
Miyaji, M.8
-
153
-
-
33747448257
-
Succesful treatment of breakthrough Trichosporon ashaii fungemia with voriconazole in a patient with acute myeloid leukemia
-
Asada N, Uryu H, Koseki M, Takeuchi M, Komatsu M, Matsue K. Succesful treatment of breakthrough Trichosporon ashaii fungemia with voriconazole in a patient with acute myeloid leukemia. Clin Infect Dis. 2006;43:e39-41.
-
(2006)
Clin Infect Dis
, vol.43
-
-
Asada, N.1
Uryu, H.2
Koseki, M.3
Takeuchi, M.4
Komatsu, M.5
Matsue, K.6
-
154
-
-
0037504006
-
Trichosporon pullulans infection in 2 patients with chronic granulomatous disease: An emerging pathogen and review of the literature
-
DOI 10.1067/mai.2003.1522
-
Moylett EH, Chinen J, Shearer WT. Trichosporon pullulans infection in 2 patientes with chronic granulomatous disease: an emerging pathogen and review of the literature. J Allergy Clin Immnunol. 2003;111:1370-4. (Pubitemid 36683694)
-
(2003)
Journal of Allergy and Clinical Immunology
, vol.111
, Issue.6
, pp. 1370-1374
-
-
Moylett, E.H.1
Chinen, J.2
Shearer, W.T.3
-
155
-
-
33744466023
-
Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis
-
DOI 10.1128/AAC.00045-06
-
Serena C, Gigaldo F, Mariné M, Pastor FJ, Guarro J. Efficacy of voriconazole in a guinea pigmodelof invasive trichosporonosis. Antimicrob Agents Chemother. 2006;50:2240-3. (Pubitemid 43807555)
-
(2006)
Antimicrobial Agents and Chemotherapy
, vol.50
, Issue.6
, pp. 2240-2243
-
-
Serena, C.1
Gilgado, F.2
Marine, M.3
Pastor, F.J.4
Guarro, J.5
-
156
-
-
18944391957
-
Fungemia due to Trichosporon asahii in a neutropenic child refractory to amphotericin B: Clearance with voriconozole
-
DOI 10.1097/01.mph.0000164865.70522.d7
-
Antachopoulos C, Papakonstantinou E, Dotis J, Bibashi E, Tamiolaki M, Koliouskas D, et al. Fungemia due Trichosporon asahii in a neutropenic child refractary to amphoteriocin B. Clearance with voriconazole. J Pediatr Hematol Oncol. 2005;27:283-5. (Pubitemid 40705811)
-
(2005)
Journal of Pediatric Hematology/Oncology
, vol.27
, Issue.5
, pp. 283-285
-
-
Antachopoulos, C.1
Papakonstantinou, E.2
Dotis, J.3
Bibashi, E.4
Tamiolaki, M.5
Koliouskas, D.6
Roilides, E.7
|